Virus interactions with endothelial cell receptors: Implications for viral pathogenesis

Current Opinion in Virology

Volumn 7, Issue 1, 2014, Pages 134-140

  Dalrymple, Nadine A ^a   MacKow, Erich R ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; ENDOTHELIAL CELL RECEPTOR; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ARTICLE; CAPILLARY PERMEABILITY; CELL FUNCTION; CLINICAL TRIAL (TOPIC); DENGUE; DENGUE VIRUS; ENDOTHELIUM CELL; HANTAVIRUS; HANTAVIRUS INFECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; ANIMAL; GENETICS; METABOLISM; PATHOGENICITY; VIROLOGY;

ANIMALS; DENGUE; DENGUE VIRUS; ENDOTHELIAL CELLS; HANTAVIRUS; HANTAVIRUS INFECTIONS; HUMANS; RECEPTORS, VIRUS;

EID: 84905197650     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2014.06.006     Document Type: Review

References (125)

1. S.M. Baumgartner-Parzer, and W.K. Waldhausl The endothelium as a metabolic and endocrine organ: its relation with insulin resistance Exp Clin Endocrinol Diabetes 109 Suppl 2 2001 S166 S179
2. W.C. Aird Endothelium as an organ system Crit Care Med 32 5 Suppl 2004 S271 S279
3. A.H. Salmon, and S.C. Satchell Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability J Pathol 226 2012 562 574
4. B.F. Becker, D. Chappell, D. Bruegger, T. Annecke, and M. Jacob Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential Cardiovasc Res 87 2010 300 310
5. A. Basu, and U.C. Chaturvedi Vascular endothelium: the battlefield of dengue viruses FEMS Immunol Med Microbiol 53 2008 287 299
6. J.S. Duchin, F.T. Koster, and C.J. Peters et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group [see comments] N Engl J Med 330 1994 949 955
7. I.N. Gavrilovskaya, E.E. Gorbunova, N.A. Mackow, and E.R. Mackow Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability J Virol 82 2008 5797 5806
8. J. Lahdevirta Clinical features of HFRS in Scandinavia as compared with East Asia Scand J Infect Dis Suppl 36 1982 93 95
9. E.R. Mackow, and I.N. Gavrilovskaya Cellular receptors and hantavirus pathogenesis Curr Top Microbiol Immunol 256 2001 91 115
10. E.R. Mackow, and I.N. Gavrilovskaya Hantavirus regulation of endothelial cell functions Thromb Haemost 102 2009 1030 1041
11. G. Valbuena, and D.H. Walker The endothelium as a target for infections Annu Rev Pathol 1 2006 171 198
12. S. Zaki, P. Greer, and L. Coffield et al. Hantavirus Pulmonary Syndrome: pathogenesis of an emerging infectious disease Am J Pathol 146 1995 552 579
13. H.F. Dvorak Vascular permeability to plasma, plasma proteins, and cells: an update Curr Opin Hematol 17 2010 225 229
14. E.C. Breen VEGF in biological control J Cell Biochem 102 2007 1358 1367
15. D.B. Cines, E.S. Pollak, and C.A. Buck et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders Blood 91 1998 3527 3561
16. B.S. Coller, and S.J. Shattil The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend Blood 112 2008 3011 3025
17. H.F. Dvorak, L.F. Brown, M. Detmar, and A.M. Dvorak Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis Am J Pathol 146 1995 1029 1039
18. M.M. Berger, C. Hesse, and C. Dehnert et al. Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema Am J Respir Crit Care Med 172 2005 763 767
19. D. Chappell, M. Westphal, and M. Jacob The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness Curr Opin Anaesthesiol 22 2009 155 162
20. S. Kunz The role of the vascular endothelium in arenavirus haemorrhagic fevers Thromb Haemost 102 2009 1024 1029
21. N. Dalrymple, and E.R. Mackow Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors J Virol 85 2011 9478 9485
22. N.A. Dalrymple, and E.R. Mackow Endothelial cells elicit immune enhancing responses to dengue virus infection J Virol 2012
23. M.G. Lampugnani, and E. Dejana The control of endothelial cell functions by adherens junctions Novartis Found Symp 283 2007 4 13 discussion 13-17, 238-241
24. M.G. Lampugnani, and E. Dejana Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis Thromb Res 120 Suppl 2 2007 S1 S6
25. J. Gavard Breaking the VE-cadherin bonds FEBS Lett 583 2009 1 6
26. E. Dejana, F. Orsenigo, and M.G. Lampugnani The role of adherens junctions and VE-cadherin in the control of vascular permeability J Cell Sci 121 Pt 13 2008 2115 2122
27. I.S. Moreira, P.A. Fernandes, and M.J. Ramos Vascular endothelial growth factor (VEGF) inhibition - a critical review Anticancer Agents Med Chem 7 2007 223 245
28. F. Bahram, and L. Claesson-Welsh VEGF-mediated signal transduction in lymphatic endothelial cells Pathophysiology 17 2010 253 261
29. H.F. Dvorak Discovery of vascular permeability factor (VPF) Exp Cell Res 312 2006 522 526
30. Y. Wang, G. Jin, H. Miao, J.Y. Li, S. Usami, and S. Chien Integrins regulate VE-cadherin and catenins: dependence of this regulation on Src, but not on Ras Proc Natl Acad Sci U S A 103 2006 1774 1779
31. N.A. McMillan, E. Payne, I.H. Frazer, and M. Evander Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells Virology 261 1999 271 279
32. T.J. Wickham, P. Mathias, D.A. Cheresh, and G.R. Nemerow Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment Cell 73 1993 309 319
33. A. Berinstein, M. Roivainen, T. Hovi, P.W. Mason, and B. Baxt Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells J Virol 69 1995 2664 2666
34. I.N. Gavrilovskaya, M. Shepley, R. Shaw, M.H. Ginsberg, and E.R. Mackow beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure Proc Natl Acad Sci U S A 95 1998 7074 7079
35. X. Wang, D.Y. Huang, S.M. Huong, and E.S. Huang Integrin alphavbeta3 is a coreceptor for human cytomegalovirus Nat Med 11 2005 515 521
36. A.L. Feire, H. Koss, and T. Compton Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain Proc Natl Acad Sci U S A 101 2004 15470 15475
37. J.J. Chu, and M.L. Ng Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells J Biol Chem 279 2004 54533 54541
38. E.F. Tewalt, J.N. Cohen, S.J. Rouhani, and V.H. Engelhard Lymphatic endothelial cells - key players in regulation of tolerance and immunity Front Immunol 3 2012 305
39. E.R. Mackow, E.E. Gorbunova, N.A. Dalrymple, and I.N. Gavrilovskaya Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches Lymphat Res Biol 11 2013 128 135
40. D.E. Schraufnagel Lung lymphatic anatomy and correlates Pathophysiology 17 2010 337 343
41. J.S. Pober, and W.C. Sessa Evolving functions of endothelial cells in inflammation Nat Rev Immunol 7 2007 803 815
42. I.N. Gavrilovskaya, E.E. Gorbunova, and E.R. Mackow Hypoxia induces permeability and giant cell responses of Andes virus-infected pulmonary endothelial cells by activating the mTOR-S6K signaling pathway J Virol 87 2013 12999 13008
43. E.E. Gorbunova, I.N. Gavrilovskaya, and E.R. Mackow Slit2-Robo4 receptor responses inhibit ANDV directed permeability of human lung microvascular endothelial cells Antiviral Res 99 2013 108 112
44. M.G. Guzman, S.B. Halstead, and H. Artsob et al. Dengue: a continuing global threat Nat Rev Microbiol 8 12 Suppl 2010 S7 S16
45. S.B. Halstead Pathophysiology S.B. Halstead, Dengue vol 5 2008 Imperial College Press London 265 326
46. K. Oishi, M. Saito, C.A. Mapua, and F.F. Natividad Dengue illness: clinical features and pathogenesis J Infect Chemother 13 2007 125 133
47. S. Noisakran, and G.C. Perng Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection Exp Biol Med (Maywood) 233 2008 401 408
48. B.E. Martina, P. Koraka, and A.D. Osterhaus Dengue virus pathogenesis: an integrated view Clin Microbiol Rev 22 2009 564 581
49. W.J. McBride, and H. Bielefeldt-Ohmann Dengue viral infections; pathogenesis and epidemiology Microbes Infect 2 2000 1041 1050
50. C. Krishnamurti, R.A. Peat, M.A. Cutting, and S.W. Rothwell Platelet adhesion to dengue-2 virus-infected endothelial cells Am J Trop Med Hyg 66 2002 435 441
51. A. Azizan, J. Sweat, C. Espino, J. Gemmer, L. Stark, and D. Kazanis Differential proinflammatory and angiogenesis-specific cytokine production in human pulmonary endothelial cells, HPMEC-ST1.6R infected with dengue-2 and dengue-3 virus J Virol Methods 138 2006 211 217
52. A. Cabrera-Hernandez, and S.R. Duncan Mammalian dengue virus receptors Dengue Bull 29 2005
53. B. Kaufmann, and M.G. Rossmann Molecular mechanisms involved in the early steps of flavivirus cell entry Microbes Infect 13 2011 1 9
54. Y. Chen, T. Maguire, and R.M. Marks Demonstration of binding of dengue virus envelope protein to target cells J Virol 70 1996 8765 8772
55. J.L. Miller, B.J. de Wet, and L. Martinez-Pomares et al. The mannose receptor mediates dengue virus infection of macrophages PLoS Pathog 4 2008 e17
56. J.A. Mondotte, P.Y. Lozach, A. Amara, and A.V. Gamarnik Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation J Virol 81 2007 7136 7148
57. B. Tassaneetrithep, T.H. Burgess, and A. Granelli-Piperno et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells J Exp Med 197 2003 823 829
58. E. Navarro-Sanchez, R. Altmeyer, and A. Amara et al. Dendritic-cell- specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses EMBO Rep 4 2003 723 728
59. P. Hilgard, and R. Stockert Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes Hepatology 32 2000 1069 1077
60. R. Germi, J.M. Crance, and D. Garin et al. Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus Virology 292 2002 162 168
61. Y. Chen, T. Maguire, and R.E. Hileman et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate Nat Med 3 1997 866 871
62. Y.L. Lin, H.Y. Lei, Y.S. Lin, T.M. Yeh, S.H. Chen, and H.S. Liu Heparin inhibits dengue-2 virus infection of five human liver cell lines Antiviral Res 56 2002 93 96
63. S. Olofsson, and T. Bergstrom Glycoconjugate glycans as viral receptors Ann Med 37 2005 154 172
64. S. Alcon-LePoder, M.T. Drouet, and P. Roux et al. The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity J Virol 79 2005 11403 11411
65. M.G. Jacobs, P.J. Robinson, C. Bletchly, J.M. Mackenzie, and P.R. Young Dengue virus nonstructural protein 1 is expressed in a glycosyl- phosphatidylinositol-linked form that is capable of signal transduction FASEB J 14 2000 1603 1610
66. S. Noisakran, T. Dechtawewat, and P. Avirutnan et al. Association of dengue virus NS1 protein with lipid rafts J Gen Virol 89 Pt 10 2008 2492 2500
67. P. Avirutnan, L. Zhang, and N. Punyadee et al. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E PLoS Pathog 3 2007 e183
68. C.F. Lin, H.Y. Lei, and A.L. Shiau et al. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide J Immunol 169 2002 657 664
69. C.F. Lin, H.Y. Lei, and A.L. Shiau et al. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage J Med Virol 69 2003 82 90
70. Y.S. Lin, C.F. Lin, and H.Y. Lei et al. Antibody-mediated endothelial cell damage via nitric oxide Curr Pharm Des 10 2004 213 221
71. P. Avirutnan, A. Fuchs, and R.E. Hauhart et al. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1 J Exp Med 207 2010 793 806
72. P. Avirutnan, R.E. Hauhart, P. Somnuke, A.M. Blom, M.S. Diamond, and J.P. Atkinson Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation J Immunol 187 2011 424 433
73. C.F. Lin, S.C. Chiu, and Y.L. Hsiao et al. Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1 J Immunol 174 2005 395 403
74. J.R. Teijaro, K.B. Walsh, and S. Cahalan et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection Cell 146 2011 980 991
75. J.A. Pawitan Dengue virus infection: predictors for severe dengue Acta Med Indones 43 2011 129 135
76. I.N. Gavrilovskaya, E.J. Brown, M.H. Ginsberg, and E.R. Mackow Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins J Virol 73 1999 3951 3959
77. I.N. Gavrilovskaya, T. Peresleni, E. Geimonen, and E.R. Mackow Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration Arch Virol 147 2002 1913 1931
78. V.S. Matthys, E.E. Gorbunova, I.N. Gavrilovskaya, and E.R. Mackow Andes virus recognition of human and Syrian hamster beta3 integrins is determined by an L33P substitution in the PSI domain J Virol 84 2009 352 360
79. T. Raymond, E. Gorbunova, I.N. Gavrilovskaya, and E.R. Mackow Pathogenic hantaviruses bind plexin-semaphorin-integrin domains present at the apex of inactive, bent alphavbeta3 integrin conformers Proc Natl Acad Sci U S A 102 2005 1163 1168
80. I. Gavrilovskaya, E.E. Gorbunova, and E.R. Mackow Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells J Virol 2010
81. E.E. Gorbunova, I.N. Gavrilovskaya, T. Pepini, and E.R. Mackow VEGFR2 and Src kinase inhibitors suppress ANDV induced endothelial cell permeability J Virol 85 2011 2296 2303
82. D.D. Kim, D.M. Kleinman, and T. Kanetaka et al. Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo Microcirculation 17 2010 128 136
83. Q. Xue, J.A. Nagy, E.J. Manseau, T.L. Phung, H.F. Dvorak, and L.E. Benjamin Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase Arterioscler Thromb Vasc Biol 29 2009 1172 1178
84. S.C. Land, and A.R. Tee Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif J Biol Chem 282 2007 20534 20543
85. N. El-Hashemite, V. Walker, H. Zhang, and D.J. Kwiatkowski Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin Cancer Res 63 2003 5173 5177
86. I.N. Gavrilovskaya, E.E. Gorbunova, and E.R. Mackow Andes virus infection of lymphatic endothelial cells causes giant cell and enhanced permeability responses that are rapamycin and vascular endothelial growth factor C sensitive J Virol 86 2012 8765 8772
87. I. Gavrilovskaya, E. Gorbunova, V. Matthys, N. Dalrymple, and E. Mackow The role of the endothelium in HPS pathogenesis and potential therapeutic approaches Adv Virol 2012 2012 467059
88. H. Christou, A. Yoshida, V. Arthur, T. Morita, and S. Kourembanas Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension Am J Respir Cell Mol Biol 18 1998 768 776
89. M. Dehler, E. Zessin, P. Bartsch, and H. Mairbaurl Hypoxia causes permeability oedema in the constant-pressure perfused rat lung Eur Respir J 27 2006 600 606
90. M. Hanaoka, Y. Droma, A. Naramoto, T. Honda, T. Kobayashi, and K. Kubo Vascular endothelial growth factor in patients with high-altitude pulmonary edema J Appl Physiol (1985) 94 2003 1836 1840
91. S.R. Hopkins, J. Garg, D.S. Bolar, J. Balouch, and D.L. Levin Pulmonary blood flow heterogeneity during hypoxia and high-altitude pulmonary edema Am J Respir Crit Care Med 171 2005 83 87
92. D. Mukhopadhyay, L. Tsiokas, X.M. Zhou, D. Foster, J.S. Brugge, and V.P. Sukhatme Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation Nature 375 1995 577 581
93. U. Scherrer, E. Rexhaj, P.Y. Jayet, Y. Allemann, and C. Sartori New insights in the pathogenesis of high-altitude pulmonary edema Prog Cardiovasc Dis 52 2010 485 492
94. X. Peng, P.M. Hassoun, and S. Sammani et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury Am J Respir Crit Care Med 169 2004 1245 1251
95. T. Sanchez, T. Estrada-Hernandez, and J.H. Paik et al. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability J Biol Chem 278 2003 47281 47290
96. G. Schmid, M. Guba, and I. Ischenko et al. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1 J Cell Biochem 101 2007 259 270
97. J. Gavard, and J.S. Gutkind VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin Nat Cell Biol 8 2006 1223 1234
98. J. Gavard, V. Patel, and J.S. Gutkind Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia Dev Cell 14 2008 25 36
99. L.M. Acevedo, S. Barillas, S.M. Weis, J.R. Gothert, and D.A. Cheresh Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor Blood 2008
100. 2+ influx Circ Res 96 2005 1282 1290
101. J. Gavard, X. Hou, and Y. Qu et al. A role for a CXCR2/ phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability Mol Cell Biol 29 2009 2469 2480
102. V. Brinkmann Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology Pharmacol Ther 115 2007 84 105
103. K. Porkka, H.J. Khoury, R.L. Paquette, Y. Matloub, R. Sinha, and J.E. Cortes Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion Cancer 116 2010 377 386
104. R.K. Jain, and L.L. Munn Leaky vessels? Call Ang1! Nat Med 6 2000 131 132
105. I. Kim, J.L. Oh, and Y.S. Ryu et al. Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells FASEB J 16 2002 126 128
106. L. Pizurki, Z. Zhou, K. Glynos, C. Roussos, and A. Papapetropoulos Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production Br J Pharmacol 139 2003 329 336
107. S.C. Satchell, K.L. Anderson, and P.W. Mathieson Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties J Am Soc Nephrol 15 2004 566 574
108. G. Thurston, J.S. Rudge, and E. Ioffe et al. Angiopoietin-1 protects the adult vasculature against plasma leakage Nat Med 6 2000 460 463
109. G. Thurston, C. Suri, and K. Smith et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 Science 286 1999 2511 2514
110. J. Igarashi, P.A. Erwin, A.P. Dantas, H. Chen, and T. Michel VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors Proc Natl Acad Sci U S A 100 2003 10664 10669
111. B.J. McVerry, and J.G. Garcia In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights Cell Signal 17 2005 131 139
112. Y. Takuwa, N. Takuwa, and N. Sugimoto The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities J Biochem (Tokyo) 131 2002 767 771
113. L. Wang, and S.M. Dudek Regulation of vascular permeability by sphingosine 1-phosphate Microvasc Res 77 2009 39 45
114. E. Gorbunova, I.N. Gavrilovskaya, and E.R. Mackow Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells J Virol 84 2010 7405 7411
115. E. Borges, Y. Jan, and E. Ruoslahti Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain J Biol Chem 275 2000 39867 39873
116. L.E. Reynolds, L. Wyder, and J.C. Lively et al. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins Nat Med 8 2002 27 34
117. S.D. Robinson, L.E. Reynolds, L. Wyder, D.J. Hicklin, and K.M. Hodivala-Dilke Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability Arterioscler Thromb Vasc Biol 24 2004 2108 2114
118. A.K. Olsson, A. Dimberg, J. Kreuger, and L. Claesson-Welsh VEGF receptor signalling - in control of vascular function Nat Rev Mol Cell Biol 7 2006 359 371
119. C.S. Goldsmith, L.H. Elliott, C.J. Peters, and S.R. Zaki Ultrastructural characteristics of Sin Nombre virus, causative agent of hantavirus pulmonary syndrome Arch Virol 140 1995 2107 2122
120. I. Pham, T. Uchida, and C. Planes et al. Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo Am J Physiol Lung Cell Mol Physiol 283 2002 L1133 L1142
121. I. Gavrilovskaya, E. Gorbunova, F. Koster, and E. Mackow Elevated VEGF levels in pulmonary edema fluid and PBMCs from patients with acute hantavirus pulmonary syndrome Adv Virol 2012 2012 674360
122. F. Koster, and E. Mackow Pathogenesis of the hantavirus pulmonary syndrome Future Virol 7 2012 41 51
123. D. Safronetz, J. Prescott, and F. Feldmann et al. Pathophysiology of hantavirus pulmonary syndrome in rhesus macaques Proc Natl Acad Sci U S A 111 2014 7114 7119
124. H.F. Dvorak, T.M. Sioussat, and L.F. Brown et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels J Exp Med 174 1991 1275 1278
125. E.A. Bustamante, H. Levy, and S.Q. Simpson Pleural fluid characteristics in hantavirus pulmonary syndrome Chest 112 1997 1133 1136